Ana Nikolic
ResearcherMOHCCN Clinician-Scientist Award Winner
MOHCCN Clinician-Scientist
Dr. Nikolic is recipient of the MOHCCN Clinicians Scientist Award. She is a neuropathologist with an interest in the molecular biology of brain tumours. She completed medical school at the University in Toronto, neuropathology residency at the University of Calgary, and a doctorate in brain tumour epigenetics at the University of Calgary in the lab of Dr. Marco Gallo.
Related Project
Network Voices
-
Why investing in early-career clinician-scientists is investing in the future of healthcare in Canada
The speed at which research is advancing our knowledge of cancer is expanding the gap between the lab and the clinic. Investing in early-career clinician-scientists is the best way to bridge this gap, explains Dr. Ana Nikolic.
-
Regional Consortia
Prairie Cancer Consortium
The overall vision of the PR2C is to create a collaborative, inclusive, equitable, and sustainable multiprovincial initiative that works towards developing new treatment strategies for patients facing...Read more
-
-
Regional Consortia
Prairie Cancer Consortium
The overall vision of the PR2C is to create a collaborative, inclusive, equitable, and sustainable multiprovincial initiative that works towards developing new treatment strategies for patients facing...Read more
-
-
Regional Consortia
Prairie Cancer Consortium
The overall vision of the PR2C is to create a collaborative, inclusive, equitable, and sustainable multiprovincial initiative that works towards developing new treatment strategies for patients facing...Read more
-
-
Regional Consortia
Prairie Cancer Consortium
The overall vision of the PR2C is to create a collaborative, inclusive, equitable, and sustainable multiprovincial initiative that works towards developing new treatment strategies for patients facing...Read more
-
-
Regional Consortia
Prairie Cancer Consortium
The overall vision of the PR2C is to create a collaborative, inclusive, equitable, and sustainable multiprovincial initiative that works towards developing new treatment strategies for patients facing...Read more
-
